Bridgewater Associates’s CONMED CNMD Stock Holding History
Bought
Maintained
Sold
Other funds holding CNMD
CB
Bridgewater Associates's CNMD Position: Q4 2025 in Review
Bridgewater Associates sold out of CONMED (CNMD) in Q4 2025, closing a stake of 5,933 shares — an estimated $279K sold.
Bridgewater Associates first reported a position in CNMD in Q3 2025 and held it in 1 quarter. The position peaked at $279K in Q3 2025. 265 funds tracked by Wall St. Rank hold CNMD as of Q4 2025.
- Bridgewater Associates reported no remaining CONMED position as of Q4 2025 after selling out during the quarter.
- Bridgewater Associates sold 5,933 CONMED shares in Q4 2025, an estimated $279K.
- Bridgewater Associates first reported a position in CONMED in Q3 2025 and held it in 1 quarter.
- Bridgewater Associates's CONMED position peaked at $279K in Q3 2025.
- 265 funds tracked by Wall St. Rank held CONMED as of Q4 2025.
Based on Bridgewater Associates's 13F filing for Q4 2025, filed 13 Feb 2026.